Four faculty in the University at Buffalo School of Pharmacy and
Pharmaceutical Sciences received new grants and awards to improve
medication management for patients and to develop novel tools for
UB will host the 15th annual Safe Schools Initiative Seminar,
Advanced School Threat Assessment Training, on March 20 in the
Center for the Arts, UB North Campus. The event is free, but
registration is required.
We don’t have to spend two years at Walden Pond to
appreciate the benefits of expressive autobiographical writing. But
the practice isn’t always constructive and a new UB study
looks at factors that might influence the benefits of expressive
New research on autism at the University at Buffalo reveals the
first evidence that it may be possible to use a single compound to
alleviate the behavioral symptoms by targeting sets of genes
involved in the disease.
A senior research scientist at UB's Research Institute on
Addictions has discovered how certain neurotransmitters are
transported and reach their targets in the brain, which could lead
to new drug therapies to help anxiety and other negative brain
New University at Buffalo research that investigated the
language preferences of Hispanic Americans seeking HIV testing in
New York found that the majority of Hispanic patients preferred to
receive care in Spanish, even if they were fluent in English.
Medical disparities — and how aspiring physicians can
begin to overcome them — is a theme of a new course begun
this semester at the Jacobs School of Medicine and Biomedical
Sciences at the University at Buffalo.
Extreme political views might be driving some people away from
churches, but the actual number of departing parishioners is not
large and those who leave are mostly marginally involved with the
institution, according to a new UB study.
William J. Jusko, PhD, SUNY Distinguished Professor in the
University at Buffalo School of Pharmacy and Pharmaceutical
Sciences, received the 2018 Oscar B. Hunter Career Award in
Therapeutics from the American Society for Clinical Pharmacology
and Therapeutics (ASCPT).
The first insights into the pathogen that does the most harm to
patients with chronic obstructive pulmonary disease (COPD) and how
it adapts to its host over months and even years, has been
published this week in the Proceedings of the National Academy of